Video

Dr. Victoria Scott on managing recurrent UTIs

Author(s):

Urology Times staff

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this video, Victoria C. Scott, MD, discusses the alternatives to immediate antibiotic treatments for recurrent urinary tract infections and how practitioners can reassure their patients through education on UTIs. Scott is a urologist at Cedars-Sinai Medical Center, Beverly Hills, California.

      Related Videos
      Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
      Why a personalized approach is key to prolapse and OAB management
      Anna Myers, CNP, answers a question during a Zoom video interview
      Anna Myers, CNP, on the overlap between urological and gynecological conditions
      Sarah Ponce discusses pelvic and vulvovaginal pain among medical trainees
      Sarah Ponce discusses pelvic and vulvovaginal pain among medical trainees
      Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
      Expert offers advice on starting a sexual wellness/aesthetics practice
      Patient talking with doctor | Image Credit: © bongkarn - stock.adobe.com
      Expert discusses pelvic pain and vesicovaginal fistula
      Shaya Taghechian, MD, answers a question during a video interview
      Dr. Taghechian on her women’s sexual health practice
      doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
      Expert urges patient education on vaginal estrogen products
      Raveen Syan, MD, FPMRS, answers a question during a Zoom video interview
      Dr. Syan shares her thoughts on SUFU 2024
      Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
      BMI may increase complications for prolapse surgery
      Cassandra K. Kisby, MD, MS, answers a question during a Zoom video interview
      Dr. Kisby on obesity in patients undergoing prolapse surgery
      Related Content
      FDA updates in urology: March 2025
      April 1st 2025

      FDA updates in urology: March 2025

      Hannah Clarke
      A recap of the FDA submissions and regulatory decisions in urology from March 2025.
      Speaking of Urology: Dr. Winter on the use of vaginal estrogen
      July 24th 2024

      Speaking of Urology: Dr. Winter on the use of vaginal estrogen

      Urology Times staff
      In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.
      Shot of a doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
      March 25th 2025

      Expert discusses unique mechanism of action of UTI treatment gepotidacin

      Ryan Haumschild, PharmD, MS, MBA, CPEL
      "I think [gepotidacin] gives a different side effect profile available to the clinicians, and I think for patients as well, it provides a better, more durable option over time," says Ryan Haumschild, PharmD, MS, MBA, CPEL.
      Dr. Malik evaluates quality of Reddit content on recurrent UTIs
      March 17th 2022

      Dr. Malik evaluates quality of Reddit content on recurrent UTIs

      Urology Times staff
      “I think we as urologists have to be proactive in providing information to our patients so that they avoid financial harm and potentially bodily harm from this sort of misinformation,” says Rena D. Malik, MD.
      Study progresses of sunobinop for interstitial cystitis/bladder pain syndrome
      March 11th 2025

      Study progresses of sunobinop for interstitial cystitis/bladder pain syndrome

      Hannah Clarke
      "The findings from this study will help us understand sunobinop’s potential as a possible new treatment option for this chronic disorder,” said Craig Landau, MD.
      Efficacy of sildenafil cream for FSAD maintained across patient subgroups
      December 16th 2024

      Efficacy of sildenafil cream for FSAD maintained across patient subgroups

      Hannah Clarke
      Age, race, and hormonal contraceptive use did not significantly impact the efficacy of sildenafil cream, 3.6%, in female sexual arousal disorder.
      © 2025 MJH Life Sciences

      All rights reserved.